A former Goldman Sachs banker in Malaysia has been extradited to the U.S. to face charges stemming from the scandal at the 1MDB state fund.
According to a report in Reuters, Malaysia’s Attorney General Roger Ng, who has been in custody since November 1, 2018, has been sent to the U.S. for a period of 10 months. Under the agreement with the US, the case against Ng has to proceed quickly so he can face charges in his home country.
Ng had agreed to be sent to the US, but the extradition was delayed because Malaysia’s government argued he should first face criminal charges in Malaysia. After talks between the two countries, it was agreed that Ng would be sent to the U.S. for that time frame. He was sent on May 3 and will return to Malaysia to face charges once the case in the U.S. is over, noted the report. The two countries can agree to extend the temporary period if needed.
In the US, Ng is facing charges of conspiracy to launder 1MDB money, as well as violating the Foreign Corrupt Practices Act. In Malaysia, he is charged with four counts of abetting Goldman Sachs in providing misleading statements to potential investors of 1MDB bonds. Tim Leissner, another ex-Goldman Sachs official, and Malaysian Financier Low Taek Jho were hit with U.S. charges over the scandal. Reuters noted that Leissner pled guilty.
Goldman Sachs is the focal point of the 1MDB scandal, in which $6.5 billion was raised via three bond sales. Of that money, the Department of Justice has estimated that $4.5 billion was misappropriated by 1MDB fund heads from 2009 to 2014. Goldman Sachs, which helped to raise money for some of the funds, has denied any wrongdoing, arguing that it was lied to by members of the former Malaysian government and 1MDB about how the proceeds from the offerings would be used. Malaysia wants Goldman Sachs to pay as much as $7.5 billion in reparation, the report noted.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas